Nevertheless, we claim that our observed reduction of FOXP3 in indomethacin treated Tregs may be beneficial to the host, shifting the balance towards a more effective immune response in long-lasting and advanced TB disease. This evidence concerns the gene FOXP3 and tuberculosis.